1.
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
by Brose, Marcia S, Dr
The Lancet (British edition), 2014, Vol.384 (9940), p.319-328
